Painful acute thyroiditis following a first cure of Ipilimumab plus Nivolumab for metastatic melanoma

被引：2
|
作者：
Montaudie, Henri [1 ,2 ]
Picard, Alexandra [1 ]
Panaia-Ferrari, Patricia [3 ]
Boukari, Feriel [1 ]
Passeron, Thierry [1 ,2 ]
Sadoul, Jean-Louis [3 ]
Brucker-Davis, Francoise [3 ]
机构：
[1] Univ Hosp Nice, Archet 2 Hosp, Dept Dermatol, Nice, France
[2] INSERM, Ctr Mediterraneen Med Mol, Nice, France
[3] Cote Azur Univ, Univ Hosp Nice, Archet 2 Hosp, Dept Endocrinol Diabetol & Reprod Med, Nice, France
来源：
MELANOMA RESEARCH | 2018年 / 28卷 / 04期
关键词：
D O I：
10.1097/CMR.0000000000000460
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：368 / 369
页数：2
相关论文
共 50 条
  • [31] Treatment of a patient with HIV and metastatic melanoma with consequitive ipilimumab and nivolumab
    Tomsitz, D.
    Hein, R.
    Biedermann, T.
    Kohlmeyer, J.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (01) : E26 - E28
  • [32] US FDA Approval Summary: Nivolumab for Treatment of Unresectable or Metastatic Melanoma Following Progression on Ipilimumab
    Hazarika, Maitreyee
    Chuk, Meredith K.
    Theoret, Marc R.
    Mushti, Sirisha
    He, Kun
    Weis, Shawna L.
    Putman, Alexander H.
    Helms, Whitney S.
    Cao, Xianhua
    Li, Hongshan
    Zhao, Hong
    Zhao, Liang
    Welch, Joel
    Graham, Laurie
    Libeg, Meredith
    Sridhara, Rajeshwari
    Keegan, Patricia
    Pazdur, Richard
    CLINICAL CANCER RESEARCH, 2017, 23 (14) : 3484 - 3488
  • [33] FDG PET in the evaluation of immune-related hypophysitis and thyroiditis following combination ipilimumab and nivolumab in advanced melanoma
    Iravani, Amir
    Galligan, Anna
    Lasocki, Arian
    Wallace, Roslyn
    Weppler, Alison
    Yeung, George Au
    Akhurst, Tim
    Sachithanandan, Nirupa
    Chiang, Cherie
    Sandhu, Shahneen
    Hicks, Rodney
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [34] Real World Outcomes of Ipilimumab and Nivolumab in Patients with Metastatic Melanoma
    Asher, Nethanel
    Ben-Betzalel, Guy
    Lev-Ari, Shaked
    Shapira-Frommer, Ronnie
    Steinberg-Silman, Yael
    Gochman, Neta
    Schachter, Jacob
    Meirson, Tomer
    Markel, Gal
    CANCERS, 2020, 12 (08) : 1 - 18
  • [35] Aseptic cystitis induced by nivolumab and ipilimumab combination for metastatic melanoma
    Schneider, Sophie
    Alezra, Eric
    Yacoub, Mokrane
    Ducharme, Oceane
    Gerard, Emilie
    Dutriaux, Caroline
    Prey, Sorilla
    MELANOMA RESEARCH, 2021, 31 (05) : 487 - 489
  • [36] Immune profiling for improving responsiveness to ipilimumab plus nivolumab checkpoint blockade treatment in patients with metastatic melanoma
    Baginska, Joanna
    Chen, Jiajia
    Tarantino, Giuseppe
    Giobbie-Hurder, Anita
    Weirather, Jason L.
    Severgnini, Mariano
    Manos, Michael
    Burke, Kelly
    Russell, Janice D.
    Brainard, Martha
    Gabriel, Elizabeth
    Brennick, Ryan
    Nazzaro, Matthew
    Hathaway, Emma
    Holovatska, Marta
    Manuszak, Claire
    Ranashinge, Srinika
    Liu, David
    Hodi, F. Stephen
    CANCER RESEARCH, 2024, 84 (06)
  • [37] irAE Coombs positive hemolytic anemia under ipilimumab plus nivolumab with subsequent nivolumab re-exposure in metastatic melanoma
    Hildebrandt, L.
    Gebhardt, C.
    Haalck, T.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 108 - 109
  • [38] Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma
    Wolchok, Jedd D.
    Chiarion-Sileni, Vanna
    Gonzalez, Rene
    Grob, Jean-Jacques
    Rutkowski, Piotr
    Lao, Christopher D.
    Cowey, C. Lance
    Schadendorf, Dirk
    Wagstaff, John
    Dummer, Reinhard
    Ferrucci, Pier Francesco
    Smylie, Michael
    Butler, Marcus O.
    Hill, Andrew
    Marquez-Rodas, Ivan
    Haanen, John B. A. G.
    Guidoboni, Massimo
    Maio, Michele
    Schoffski, Patrick
    Carlino, Matteo S.
    Lebbe, Celeste
    McArthur, Grant
    Ascierto, Paolo A.
    Daniels, Gregory A.
    Long, Georgina, V
    Bas, Tuba
    Ritchings, Corey
    Larkin, James
    Hodi, F. Stephen
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (02) : 127 - +
  • [39] Nivolumab plus ipilimumab in metastatic uveal melanoma: a real-life, retrospective cohort of 47 patients
    Salaun, Helene
    de Koning, Leanne
    Saint-Ghislain, Mathilde
    Servois, Vincent
    Ramtohul, Toulsie
    Garcia, Agathe
    Matet, Alexandre
    Cassoux, Nathalie
    Mariani, Pascale
    Piperno-Neumann, Sophie
    Rodrigues, Manuel
    ONCOIMMUNOLOGY, 2022, 11 (01):
  • [40] The efficacy of combination immunotherapy with ipilimumab plus nivolumab in metastatic myxofibrosarcoma
    Kalofonou, Foteini
    Napolitano, Andrea
    Benson, Charlotte
    Miah, Aisha
    Zaidi, Shane
    Lindsay, Daniel
    Thway, Khin
    Jones, Robin L.
    RARE TUMORS, 2024, 16
12345